Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Lapatinib | 0.31623 | uM | 9 | 625.00 | 414.82 | 548.00 | 785.00 | 0.6981 | 0.3533 |
| SK-BR-3 | Linsitinib | 0.31623 | uM | 9 | 625.00 | 414.82 | 1089.00 | 785.00 | 1.3873 | 1.8544 |
| SK-BR-3 | Lapatinib | 0.01 | uM | 9 | 625.00 | 414.82 | 684.00 | 785.00 | 0.8713 | 0.7220 |
| SK-BR-3 | Linsitinib | 0.031623 | uM | 9 | 625.00 | 414.82 | 1005.00 | 785.00 | 1.2803 | 1.6160 |
| SK-BR-3 | Erlotinib | 0.031623 | uM | 9 | 625.00 | 414.82 | 818.00 | 785.00 | 1.0420 | 1.0915 |
| SK-BR-3 | Erlotinib | 1 | uM | 9 | 625.00 | 414.82 | 703.00 | 785.00 | 0.8955 | 0.7740 |
| SK-BR-3 | 17-AAG | 0.000302 | uM | 9 | 625.00 | 414.82 | 903.00 | 785.00 | 1.1503 | 1.3287 |
| SK-BR-3 | Lapatinib | 3.1623 | uM | 9 | 625.00 | 414.82 | 404.00 | 785.00 | 0.5147 | -0.0283 |
| SK-BR-3 | 17-AAG | 0.31623 | uM | 9 | 625.00 | 414.82 | 324.00 | 785.00 | 0.4127 | -0.2355 |
| SK-BR-3 | 0 | uM | 9 | 625.00 | 414.82 | 623.00 | 785.00 | 0.7936 | 0.5558 | |
| SK-BR-3 | 0 | uM | 9 | 625.00 | 414.82 | 691.00 | 785.00 | 0.8803 | 0.7412 | |
| SK-BR-3 | Linsitinib | 1 | uM | 9 | 625.00 | 414.82 | 692.00 | 785.00 | 0.8815 | 0.7439 |
| SK-BR-3 | Erlotinib | 0.31623 | uM | 9 | 625.00 | 414.82 | 705.00 | 785.00 | 0.8981 | 0.7795 |
| SK-BR-3 | 0 | uM | 9 | 625.00 | 414.82 | 850.00 | 785.00 | 1.0828 | 1.1806 | |
| SK-BR-3 | Linsitinib | 19.9526 | uM | 9 | 625.00 | 414.82 | 582.00 | 785.00 | 0.7414 | 0.4448 |
| SK-BR-3 | Linsitinib | 0.0033113 | uM | 9 | 625.00 | 414.82 | 843.00 | 785.00 | 1.0739 | 1.1611 |
| SK-BR-3 | Erlotinib | 10 | uM | 9 | 625.00 | 414.82 | 462.00 | 785.00 | 0.5885 | 0.1242 |
| SK-BR-3 | Erlotinib | 3.1623 | uM | 9 | 625.00 | 414.82 | 612.00 | 785.00 | 0.7796 | 0.5259 |
| SK-BR-3 | 17-AAG | 0.0031623 | uM | 9 | 625.00 | 414.82 | 890.00 | 785.00 | 1.1338 | 1.2923 |
| SK-BR-3 | Erlotinib | 0.01 | uM | 9 | 625.00 | 414.82 | 898.00 | 785.00 | 1.1439 | 1.3147 |
| SK-BR-3 | Linsitinib | 0.01 | uM | 9 | 625.00 | 414.82 | 1088.00 | 785.00 | 1.3860 | 1.8515 |
| SK-BR-3 | 17-AAG | 0.0001 | uM | 9 | 625.00 | 414.82 | 967.00 | 785.00 | 1.2318 | 1.5086 |
| SK-BR-3 | 17-AAG | 0.01 | uM | 9 | 625.00 | 414.82 | 642.00 | 785.00 | 0.8178 | 0.6074 |
| SK-BR-3 | Linsitinib | 10 | uM | 9 | 625.00 | 414.82 | 643.00 | 785.00 | 0.8191 | 0.6101 |
| SK-BR-3 | 0 | uM | 9 | 625.00 | 414.82 | 813.00 | 785.00 | 1.0357 | 1.0776 |